Oncosil Medical Ltd
ASX:OSL
Oncosil Medical Ltd
ASX:OSL
Price:
0.625
AUD
-0.79%
Market Closed
Market Cap:
AU$13.7m
Relative Value
The Relative Value of one
OSL
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.625 AUD,
Oncosil Medical Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OSL Relative Value
HIDDEN
Multiples Across Competitors
OSL Competitors Multiples
Oncosil Medical Ltd Competitors
Oncosil Medical Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Oncosil Medical Ltd
ASX:OSL
|
13.7m AUD | 10.9 | -0.9 | -0.6 | -0.6 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 364 | 4 310.7 | 1 235.1 | 2 378.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
188.7B USD | 4.2 | 28.2 | 19.7 | 26.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
138.6B USD | 5.6 | 38.3 | 19.5 | 28.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.8B CHF | 5.3 | 36.8 | 27.3 | 27.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
267.7B CNY | 6 | 17.9 | 17.9 | 17.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.7B USD | 4.6 | 25.3 | 19.9 | 23.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
30B USD | 9.4 | 46.5 | 30 | 37.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.8B USD | 1.8 | 22 | 12.1 | 18.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.8B USD | 6.2 | 28.5 | 21.2 | 23.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
